Relationships between cholesterol, apolipoprotein E polymorphism and dementia: A cross-sectional analysis from the PAQUID study

Neuroepidemiology

Volumn 19, Issue 3, 2000, Pages 141-148

  Bonarek, Mojgan ^a   Barberger Gateau, Pascale ^a   Letenneur, Luc ^a   Deschamps, Valérie ^a   Iron, Albert ^b   Dubroca, Bénédicte ^a   Dartigues, Jean François ^a  

^a INSERM   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Apolipoprotein E; Case control study; Cholesterol; Dementia; Elderly

Indexed keywords

APOLIPOPROTEIN E4; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; ALZHEIMER DISEASE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; FEMALE; HUMAN; MALE; MULTIINFARCT DEMENTIA; PROTEIN POLYMORPHISM; RISK ASSESSMENT; RISK FACTOR;

EID: 0034020875     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026249     Document Type: Article

References (25)

1. Notkola IL, Sulkava R, Pekkanen J, Erkinjuntti T, Ehnholm C, Kivinen P, Tuomilehto A, Nissinen A: Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology 1998;17:14-20.
2. Chandra V, Pandav R: Gene-environment interaction in Alzheimer's disease: A potential role for cholesterol. Neuroepidemiology 1998;17: 225-232.
3. Kalmijn S, Launer LJ, Ott A, Witteman JCM, Hofman A, Breteler MMB: Dietary fat intake and the risk of incident dementia in the Rotterdam study. Ann Neurol 1997;42: 776-782.
4. Kalmijn S. Feskens EJM, Launer LJ, Kromhout D: Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men. Am J Epidemiol 1997;145:33-41.
5. Pradignac A, Schlienger JL, Velten M, Mejean L: Relationships between macronutrient intake, handicaps, and cognitive impairments in free living elderly people. Aging Clin Exp Res 1995;7:67-74.
6. Benton D: Do low cholesterol levels slow mental processing? Psychosomatic Med 1995;57:50-53.
7. Wada T, Matsubayashi K, Okumiya K, Kimura S, Osaka Y, Doi Y, Ozawa T: Lower serum cholesterol level and later decline in cognitive function in older people living in the community, Japan. J Am Geriatr Soc 1997;45:1411-1412.
8. Wada T, Matsubayashi K, Okumiya K, Kimura S, Osaki Y, Doi Y, Ozawa T: Serum cholesterol levels and cognitive function assessed by P300 latencies in an older population living in the community. J Am Geriatr Soc 1997;45:122-123.
9. Lehtonen A, Luutonen S: High-density lipoprotein cholesterol levels of very old people in the diagnosis of dementia. Age Ageing 1986;15:267-270.
10. Giubilei F, D'Antona R, Antonini R, Lenzi GL, Ricci G, Fieschi C: Serum lipoprotein pattern variations in dementia and ischemic stroke. Acta Neurol Scand 1990;81: 84-86.
11. Kuo YM, Emmerling MR, Bisgaier CL, Essenburg Ad, Lampert HC, Drumm D, Roher AE: Elevated low-density lipoprotein in Alzheimer's disease correlates with brain A beta 1-42 levels. Biochem Biophys Res Commun 1998;252:711-715.
12. Dartigues JF, Gagnon M, Barberger-Gateau P, Letenneur L, Commenges D, Sauvel C, Michel P, Salamon R: The PAQUID epidemiological program on brain aging. Neuroepidemiology 1992;11:14-18.
13. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 3, rev. (DSM-III-R). Washington, APA, 1987.
14. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
15. Richard P, Thomas G, de Zulueta MP, De Gennes JL, Thomas M, Cassaigne A, Bereziat G, Iron A: Common and rare genotypes of human apolipoprotein E determined by specific restriction profiles of polymerase chain reaction-amplified DNA. Clin Chem 1994;40:24-29.
16. Barrett-Connor E, Edelstein SL, Corey-Bloom J, Wiederholt WC: Weight loss precedes dementia in community-dwelling older adults. J Am Geriatr Soc 1996;44:1147-1152.
17. Hofman A, Ott A, Breteler MMB, Bots ML, Slooter AJC, van Harskamp F, van Dujin CN, Van Broeckhoven C. Grobbee DE: Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study. Lancet 1997;349:151-154.
18. Slooter AJC, Tang M-X, van Dujin CM, Stern Y, Ott A, Bell K, Breteler MMB, Van Broeckhoven C, Tatemichi TK, Tycko B, Hofman A, Mayeux R: Apolipoprotein E ε4 and the risk of dementia with stroke. A population-based investigation. JAMA 1997;277:818-821.
19. Simons M, Keller P, DeStrooper B, Beyreuther K, Dotti CG, Simons K: Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc Natl Acad Sci USA 1998;95:6460-6464.
20. Weindruch R, Sohal RS: Caloric intake and aging. N Engl J Med 1997; 337:986-994.
21. Thome J, Gsell W, Rosler M, Kornhuber J, Frolich L, Hashimoto E, Zielke B, Wiesbeck GA, Riederer P: Oxidative-stress associated parameters (lactoferrin, superoxide dismutase) in serum of patients with Alzheimer's disease. Life Sci 1997; 60:13-19.
22. Cummings JL, Vinters HV, Cole GM, Khachaturian ZS: Alzheimer's disease. Etiologies, pathophysiology, cognitive reserve, treatment opportunities. Neurology 1998;51(suppl 1):S2-S17.
23. Hayek T, Oiknine J, Dankner G, Brook J, Aviram M: HDL apolipoprotein A-I attenuates oxidative modification of low density lipoprotein: Studies in transgenic mice. Eur J Clin Chem Clin Biochem 1995;33: 721-725.
24. Mulder M, Ravid R, Swaab DF, DeKloet ER, Haasdijk ED, Julk J, van der Boom J, Havekes LM: Reduced levels of cholesterol, phospholipids, and fatty acids in cerebrospinal fluid of Alzheimer disease patients are not related to apolipoprotein E4. Alzheimer Dis Assoc Disord 1998;12:198-203.
25. Carmelli D, Swan GE, Reed T, Schellenberg GD, Christian JC: The effect of apolipoprotein E epsilon 4 in the relationships of smoking and drinking to cognitive function. Neuroepidemiology 1999;18:125-133.